Stock Research for GENE

GENE

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

GENE Stock Chart & Research Data

The GENE chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the GENE chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


GENE Due diligence Resources & Stock Charts

The GENE stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View GENE Detailed Price Forecast - CNN Money CNN View GENE Detailed Summary - Google Finance
Yahoo View GENE Detailed Summary - Yahoo! Finance Zacks View GENE Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View GENE Trends & Analysis - Trade-Ideas Barrons View GENE Major Holders - Barrons
NASDAQ View GENE Call Transcripts - NASDAQ Seeking View GENE Breaking News & Analysis - Seeking Alpha
Spotlight View GENE Annual Report - CompanySpotlight.com OTC Report View GENE OTC Short Report - OTCShortReport.com
TradeKing View GENE Fundamentals - TradeKing Charts View GENE SEC Filings - Bar Chart
WSJ View Historical Prices for GENE - The WSJ Morningstar View Performance/Total Return for GENE - Morningstar
MarketWatch View the Analyst Estimates for GENE - MarketWatch CNBC View the Earnings History for GENE - CNBC
StockMarketWatch View the GENE Earnings - StockMarketWatch MacroAxis View GENE Buy or Sell Recommendations - MacroAxis
Bullish View the GENE Bullish Patterns - American Bulls Short Pains View GENE Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View GENE Stock Mentions - StockTwits PennyStocks View GENE Stock Mentions - PennyStockTweets
Twitter View GENE Stock Mentions - Twitter Invest Hub View GENE Investment Forum News - Investor Hub
Yahoo View GENE Stock Mentions - Yahoo! Message Board Seeking Alpha View GENE Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for GENE - SECform4.com Insider Cow View Insider Transactions for GENE - Insider Cow
CNBC View GENE Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for GENE - OTC Markets
Yahoo View Insider Transactions for GENE - Yahoo! Finance NASDAQ View Institutional Holdings for GENE - NASDAQ


Stock Charts

FinViz View GENE Stock Insight & Charts - FinViz.com StockCharts View GENE Investment Charts - StockCharts.com
BarChart View GENE Stock Overview & Charts - BarChart Trading View View GENE User Generated Charts - Trading View


Latest Financial News for GENE

Invictus MD Strategies Corp. Opens the Market
Posted on Tuesday March 20, 2018

Invictus MD Strategies Corp. Opens the Market


Genetic Technologies Limited Announces Further Collaborative Research with The University of Melbourne to Broaden the Applicability of the BREVAGenplus® Breast Cancer Risk Assessment Test
Posted on Friday March 16, 2018

MELBOURNE, Australia, March 16, 2018-- Genetic Technologies Limited, a diversified molecular diagnostics company embracing blockchain technologies across genomic testing platforms, announced today the ...


Shivom Partnership With Genetic Technologies Will Enable Better Cancer Prediction and Prevention Through Mass Genomic Data Analysis
Posted on Tuesday March 06, 2018

NASDAQ: GENE) to accelerate the prediction of cancer for millions of individuals worldwide. GTG, whose lead product is BREVAGenplus® - a clinically validated risk assessment test for non-hereditary breast cancer - is at the forefront of preventive medicine.


Genetic Technologies Limited: Project Shivom Strategic Alliance
Posted on Tuesday March 06, 2018

MELBOURNE, Australia, March 06, 2018-- Genetic Technologies Limited a diversified molecular diagnostics company; provider of BREVAGen plus ®, a first-in-class, clinically validated risk assessment test ...


Enter a stock symbol to view the stock details.